Naltrexone Hcl Powder
NDC Package 82393-111-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Naltrexone Hcl powders is a medication used to prevent people who have been addicted to certain drugs (opiates) from taking them again. This formulation utilizes a powder delivery system. Marketed by Pharma Source Direct, Inc., this product is identified by NDC 82393-111.

Identification & Billing

NDC Package Code
82393-111-06
Package Description
.01 kg in 1 BOTTLE, PLASTIC
Product Code
82393-111
11-Digit Billing Format
82393011106

Clinical Specifications

Proprietary Name
Naltrexone Hcl
Non-Proprietary Name
Naltrexone Hcl
Substance Name
Naltrexone Hydrochloride
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
NALTREXONE HYDROCHLORIDE 1 kg/kg
Usage Information
This medication is used to prevent people who have been addicted to certain drugs (opiates) from taking them again. It is used as part of a complete treatment program for drug abuse (e.g., compliance monitoring, counseling, behavioral contract, lifestyle changes). This medication must not be used in people currently taking opiates, including methadone. Doing so can cause sudden withdrawal symptoms. Naltrexone belongs to a class of drugs known as opiate antagonists. It works in the brain to prevent opiate effects (e.g., feelings of well-being, pain relief). It also decreases the desire to take opiates. This medication is also used to treat alcohol abuse. It can help people drink less alcohol or stop drinking altogether. It also decreases the desire to drink alcohol when used with a treatment program that includes counseling, support, and lifestyle changes.

Regulatory & Marketing

Labeler Name
Pharma Source Direct, Inc.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
12-07-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (82393-111). Click a package code to view its specific billing and regulatory data.

82393-111-04
.001 kg in 1 BOTTLE, PLASTIC
82393-111-05
.005 kg in 1 BOTTLE, PLASTIC
82393-111-07
.025 kg in 1 BOTTLE, PLASTIC
82393-111-08
.1 kg in 1 BOTTLE, PLASTIC
82393-111-10
.5 kg in 1 BOTTLE, PLASTIC
82393-111-11
1 kg in 1 BOTTLE, PLASTIC
82393-111-14
10 kg in 1 DRUM
82393-111-15
15 kg in 1 DRUM
82393-111-16
20 kg in 1 DRUM
82393-111-17
25 kg in 1 DRUM

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82393-111-06 identifies a specific commercial package of .01 kg in 1 bottle, plastic of Naltrexone Hcl (UNFINISHED drug), a bulk ingredient labeled by Pharma Source Direct, Inc.. This powder is formulated for use and contains naltrexone hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pharma Source Direct, Inc. on December 07, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to prevent people who have been addicted to certain drugs (opiates) from taking them again. It is used as part of a complete treatment program for drug abuse (e.g., compliance monitoring, counseling, behavioral contract, lifestyle changes). This medication must not be used in people currently taking opiates, including methadone. Doing so can cause sudden withdrawal symptoms. Naltrexone belongs to a class of drugs known as opiate antagonists. It works in the brain to prevent opiate effects (e.g., feelings of well-being, pain relief). It also decreases the desire to take opiates. This medication is also used to treat alcohol abuse. It can help people drink less alcohol or stop drinking altogether. It also decreases the desire to drink alcohol when used with a treatment program that includes counseling, support, and lifestyle changes.

How is this Pharma Source Direct, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82393011106. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82393-111-06
11-Digit CMS (5-4-2)
82393-0111-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.